Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Work In Process (2021 - 2022)

Pulse Biosciences (PLSE) has 2 years of Work In Process data on record, last reported at $1.8 million in Q2 2022.

  • For Q2 2022, Work In Process changed N/A year-over-year to $1.8 million; the TTM value through Jun 2022 reached $1.8 million, changed N/A, while the annual FY2021 figure was $1.4 million, N/A changed from the prior year.
  • Work In Process reached $1.8 million in Q2 2022 per PLSE's latest filing, up from $1.7 million in the prior quarter.
  • Across five years, Work In Process topped out at $1.8 million in Q2 2022 and bottomed at $1.2 million in Q3 2021.